Azitra (AZTR) Total Liabilities (2022 - 2026)
Azitra (AZTR) reported Total Liabilities of $1.6 million for Q1 2026, up 9.75% on a YoY basis from $1.5 million in Q1 2025, and up 34.5% quarter-over-quarter from $1.2 million in Q4 2025.
Azitra (AZTR) Total Liabilities (2022 - 2026) Analysis & Trends
Azitra has reported Total Liabilities for 5 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 9.75% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 9.75% YoY), and the FY2025 full-year result was $1.2 million, down 26.28% from the prior year.
- Total Liabilities for Q1 2026 stood at $1.6 million, up from $1.2 million in the prior quarter.
- The five-year high for Total Liabilities was $38.7 million in Q1 2023, with the low at $1.2 million in Q4 2025.
- Historically, Total Liabilities has averaged $8.3 million across 5 years, with a median of $2.1 million in 2024.
- Annual changes were most pronounced in 2024 — Total Liabilities sank 95.49% — and 2025, when it advanced 17.56%.
- Azitra's Total Liabilities stood at $9.7 million in 2022, then sank by 77.37% to $2.2 million in 2023, then decreased by 24.6% to $1.7 million in 2024, then slipped by 26.28% to $1.2 million in 2025, then soared by 34.5% to $1.6 million in 2026.
- The last three Total Liabilities figures came in at $1.6 million (Q1 2026), $1.2 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 38.68 Mn |
| Dec 31, 2022 | 9.73 Mn |
| Sep 30, 2022 | 32.24 Mn |
| Jun 30, 2022 | 29.87 Mn |